PharmaEngine, Inc. (TPEX:4162)
Taiwan · Delayed Price · Currency is TWD 64.60
+0.10 (0.16%)
Feb 11, 2026, 1:30 PM CST
PharmaEngine Market Cap
PharmaEngine has a market cap or net worth of 9.28 billion as of February 11, 2026. Its market cap has decreased by -32.07% in one year.
Market Cap
9.28B
Enterprise Value
4.69B
Revenue
2.51B
Ranking
n/a
PE Ratio
5.55
Stock Price
64.60
Market Cap Chart
Since September 1, 2011, PharmaEngine's market cap has increased from 5.38B to 9.28B, an increase of 72.56%. That is a compound annual growth rate of 3.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 9.28B | -8.24% |
| Dec 31, 2025 | 10.11B | -22.04% |
| Dec 31, 2024 | 12.97B | -14.41% |
| Dec 29, 2023 | 15.16B | -15.60% |
| Dec 30, 2022 | 17.96B | 75.96% |
| Dec 30, 2021 | 10.21B | 21.08% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AP Biosciences | 14.38B |
| Ever Supreme Bio Technology | 13.31B |
| Tanvex BioPharma | 12.74B |
| Medigen Vaccine Biologics | 11.80B |
| TCM Biotech International | 10.72B |
| Gongwin Biopharm Holdings | 8.96B |
| TaiGen Biopharmaceuticals Holdings | 8.61B |
| Acepodia | 7.92B |